ロード中...
Private Payer Coverage Policies for ApoE-e4 Genetic Testing
PURPOSE: ApoE-e4 has a well-established connection to late-onset Alzheimer’s disease (AD) and is available clinically. Yet, there have been no analyses of payer coverage policies for ApoE. Our objective is to analyze private payer coverage policies for ApoE genetic testing, examine the rationales, a...
保存先:
| 出版年: | Genet Med |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8035237/ https://ncbi.nlm.nih.gov/pubmed/33420342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41436-020-01042-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|